Related Experiment Videos

Idiotype vaccination of myeloma patients after chemotherapy

¹Divisione di Ematologia dell'Universita di Torino, Azienda Ospedaliera San Giovanni Battista, Italy.

Acta Oncologica (Stockholm, Sweden)

|January 6, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report.

Journal of medical case reports·2025

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.

American journal of hematology·2024

Anticancer innovative therapy: Highlights from the ninth annual meeting.

Cytokine & growth factor reviews·2019

Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD

Oncoimmunology·2018

Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2013

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.

Leukemia·2011

See all related articles